B of A Securities Initiates Coverage On CG Oncology With Buy Rating, Announces Price Target of $65
B of A Securities Initiates Coverage On CG Oncology With Buy Rating, Announces Price Target of $65
美銀證券開始對塔吉特腫瘤進行買入評級，並宣佈其目標價爲65美元。
B of A Securities analyst Charlie Yang initiates coverage on CG Oncology (NASDAQ:CGON) with a Buy rating and announces Price Target of $65.
美銀證券分析師Charlie Yang開始對CG Oncology（納斯達克：CGON）進行覆蓋，給予買入評級併發布65美元的目標價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。